What Research Can and Cannot Tell You Human DSIP research exists, but it is limited and not enough to create a reliable dosing standard for everyday sleep problems
In a 12-week clinical study, obese participants taking 1 mg of AOD-9604 daily lost about 2.62.8 kg (56 lbs) on average more than triple the weight loss of the placebo group
Known for boosting energy, improving mood, and supporting the nervous system, these injections are essential for individuals with dietary restrictions or absorption issues
One study found that circulating DSIP levels were lowest at night and highest in the afternoon, the opposite of what researchers would expect from a simple sleep-promoting factor
The aim, of course, is a more normalized tissue architecture, a significant goal for GHK-Cu for scar reduction